BIOMAT Database Logo BIOMAT Database Logo

Blood pressure in early autosomal dominant polycystic kidney disease. 2014

Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
From the University of Colorado, Denver (R.W.S., G.B.); University of Pittsburgh School of Medicine, Pittsburgh (K.Z.A., K.T.B., C.G.M.); Tufts Medical Center (R.D.P., D.C.M.) and Beth Israel Deaconess Medical Center (T.I.S., P.G.C.) - both in Boston; Mayo Clinic College of Medicine, Rochester, MN (V.E.T., M.C.H., P.C.H.); Cleveland Clinic, Cleveland (W.E.B.); Kansas University Medical Center, Kansas City (F.T.W., J.J.G.); Emory University School of Medicine, Atlanta (F.F.R.-O., A.B.C.); and the National Institutes of Health, Bethesda, MD (M.F.F.).

BACKGROUND Hypertension is common in autosomal dominant polycystic kidney disease (ADPKD) and is associated with increased total kidney volume, activation of the renin-angiotensin-aldosterone system, and progression of kidney disease. METHODS In this double-blind, placebo-controlled trial, we randomly assigned 558 hypertensive participants with ADPKD (15 to 49 years of age, with an estimated glomerular filtration rate [GFR] >60 ml per minute per 1.73 m(2) of body-surface area) to either a standard blood-pressure target (120/70 to 130/80 mm Hg) or a low blood-pressure target (95/60 to 110/75 mm Hg) and to either an angiotensin-converting-enzyme inhibitor (lisinopril) plus an angiotensin-receptor blocker (telmisartan) or lisinopril plus placebo. The primary outcome was the annual percentage change in the total kidney volume. RESULTS The annual percentage increase in total kidney volume was significantly lower in the low-blood-pressure group than in the standard-blood-pressure group (5.6% vs. 6.6%, P=0.006), without significant differences between the lisinopril-telmisartan group and the lisinopril-placebo group. The rate of change in estimated GFR was similar in the two medication groups, with a negative slope difference in the short term in the low-blood-pressure group as compared with the standard-blood-pressure group (P<0.001) and a marginally positive slope difference in the long term (P=0.05). The left-ventricular-mass index decreased more in the low-blood-pressure group than in the standard-blood-pressure group (-1.17 vs. -0.57 g per square meter per year, P<0.001); urinary albumin excretion was reduced by 3.77% with the low-pressure target and increased by 2.43% with the standard target (P<0.001). Dizziness and light-headedness were more common in the low-blood-pressure group than in the standard-blood-pressure group (80.7% vs. 69.4%, P=0.002). CONCLUSIONS In early ADPKD, the combination of lisinopril and telmisartan did not significantly alter the rate of increase in total kidney volume. As compared with standard blood-pressure control, rigorous blood-pressure control was associated with a slower increase in total kidney volume, no overall change in the estimated GFR, a greater decline in the left-ventricular-mass index, and greater reduction in urinary albumin excretion. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; HALT-PKD [Study A] ClinicalTrials.gov number, NCT00283686.).

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration

Related Publications

Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Blood pressure in early autosomal dominant polycystic kidney disease.
March 2015, The New England journal of medicine,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Blood pressure in early autosomal dominant polycystic kidney disease.
March 2015, The New England journal of medicine,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Blood pressure in early autosomal dominant polycystic kidney disease.
March 2015, The New England journal of medicine,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Blood pressure in early autosomal dominant polycystic kidney disease.
March 2015, The New England journal of medicine,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Progress in blood pressure control in autosomal dominant polycystic kidney disease.
August 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Blood pressure and renal function in autosomal dominant polycystic kidney disease.
October 1997, Pediatric nephrology (Berlin, Germany),
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.
January 2014, Kidney & blood pressure research,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.
October 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Early renal abnormalities in autosomal dominant polycystic kidney disease.
June 2010, Clinical journal of the American Society of Nephrology : CJASN,
Robert W Schrier, and Kaleab Z Abebe, and Ronald D Perrone, and Vicente E Torres, and William E Braun, and Theodore I Steinman, and Franz T Winklhofer, and Godela Brosnahan, and Peter G Czarnecki, and Marie C Hogan, and Dana C Miskulin, and Frederic F Rahbari-Oskoui, and Jared J Grantham, and Peter C Harris, and Michael F Flessner, and Kyongtae T Bae, and Charity G Moore, and Arlene B Chapman, and
Autosomal dominant polycystic kidney disease.
September 2014, American family physician,
Copied contents to your clipboard!